TIAFT99 left strip
  TIAFT logo

TIAFT 2000

The International Association of Forensic Toxicologists
38th International Meeting
13-17 August, 2000, HELSINKI, FINLAND
Welcome to Finland

P O S T E R S

 

Topics:

TIAFT 2000 homepage

Programme

Posters

Pictures



 
finnair
OFFICIAL CARRIER
pix
pix
pix

The posters of Sessions I-III are shown 14-15 August and the posters of Sessions IV-VII are shown 16-17 August at the Poster Exhibition Area.
The poster discussion times are as indicated below.

 
Monday 14 August
 
15:00-16:00  Poster Session I: New Analytical Technologies
 
  • Detection of the neuroleptics clozapine, haloperidol, penfluridol and thioridazine in hair of psychiatric patients by LC/MS/MS
    C. Muller, A. Frei, W. Weinmann (Freiburg, Germany and Basel, Switzerland)
  • Detection of illicit heroin markers in urine with liquid chromatography-atmospheric pressure chemical ionization mass spectrometry
    M.J. Bogusz, R.D. Maier, M. Erkens, U. Kohls (Aachen, Germany)
  • HPLC of basic drugs on microparticulate strong cation-exchange materials
    R.J. Flanagan, E.P. Spencer (London, UK)
  • Application of non-conditioned solid phase extraction in the isolation of amphetamine from post-mortem biological material
    N. Raikos, H. Tsoukali, D. Psaroulis, V. Mirtsou (Thessaloniki, Greece)
  • Identification of buprenorphine and norbuprenorphine in urine by gas chromatography-mass spectrometry
    U.-M. Laakkonen, A. Leinonen (Helsinki, Finland)
  • Detection and quantitation of beta-blocker drugs in whole blood using LC/MS/MS
    K.A. Brooking, R.M. Berezowski, S.J. Dickson, L.I. Stowell (Lower Hutt, New Zealand)
  • Screening for neuromuscular blocking drugs (quaternary amines) in whole blood by using ion trap LC-(ESI)MS- method and two case reports
    C.H.M. Kerskes, K.J. Lusthof, P.G.M. Zweipfenning (Rijswijk and Groningen, The Netherlands)
  • Ion-Spray LC-MS for screening of benzodiazepines in human urine and blood samples
    M. Josefsson, R. Kronstrand (Linkoping, Sweden)
  • Comparison of EI GC-MS and IS LC-MS for the detection of benzodiazepines in urine
    R. Kronstrand, M. Josefsson, I. Nystrom (Linkoping, Sweden)
  • Determination of various benzodiazepines together with zopiclone and zolpidem by GC/MS after silylation
    E. Ali-Tolppa, S. Mykkanen, K. Ariniemi, P. Lillsunde (Helsinki, Finland)
  • KONE Pro-analyzer results compared with thin layer chromatographic (TLC) and gas chromatography/mass spectrometric results (GC/MS)
    P. Nummi, A. Holopainen, H. Lampinen, S. Mykkanen, J. Rautamaki, M. Kurki, P. Lillsunde (Helsinki, Jarvenpaa and Espoo, Finland)
  • Determination of buprenorphine and norbuprenorphine in serum samples by HPLC with electrochemical detection
    P. Nummi, K. Ariniemi, P. Lillsunde (Helsinki, Finland)
  • LC-MS analysis of psychiatric drugs at high pH
    K.E. Goeringer, I.M. McIntyre, O.H. Drummer (Southbank, Victoria, Australia)
  • GC-MS determination of benzodiazepines in blood and urine after derivatization with propylation and propionylation
    S. Suominen, S. Mykkanen, P. Lillsunde (Helsinki, Finland)
  • Evaluation of usefulness for drug of abuse screening based on KIMS Technology
    S. Mykkanen, A. Helin, L. Melamies, O. Peltola, P. Lillsunde (Helsinki, Espoo and Turku, Finland)
  • Laser-microscopical measurement of the tobramycin-concentration in nerve cells
    M. Mukaida, H. Kimura, Y. Takada-Matsuzaki, N. Tachibana (Tokorozawa and Tokyo, Japan)
  • Enzyme-linked immunoassay for tetrahydrocannabinols and their metabolites with a monoclonal antibody
    I. Yamamoto, K. Watanabe, M. Matsuda, Y. Tateoka, N. Usami, T. Matsunaga, H. Tanaka, Y. Shoyama, H. Yoshimura (Kanazawa and Fukuoka, Japan)
  • Analysis of GHB in whole blood by head-space solid-phase microextraction (SPME) and capillary gas chromatography
    H. Aspelund, M. Krogh, A.S. Christophersen (Oslo, Norway)
  • High-performance liquid chromatographic determination of zopiclone and zolpidem in whole blood
    R. Karinen, I. Hasvold, A.S. Christophersen (Oslo, Norway)
  • Atmosphere-pressure surface-ionization indicator of opioids
    U.Kh. Rasulev, U. Khasanov, V.V. Palitcin (Tashkent, Uzbekistan)
  • A rapid instrumented fluorescence immunoassay for the detection of cocaine in oral fluids
    D. Nam, G. Wang, F. Westhout, T. Foley (Rancho Cucamonga, CA, USA)
  • Spectra interference between diquat and paraquat by derivate spectrophotometry
    T.-l. Kuo, D.-L. Lin (Taipei, Taiwan)


Tuesday 15 August
 
10:00-11:00  Poster Session II: Alcohol, Drugs, and Driving
 
  • Driving under the influence of drugs - police protocol if reduced driving capacity is suspected
    W. Bernhard, B. Aebi (Bern, Switzerland)
  • A computer-based quality control program for evidential breath analysers
    M. Portman, P. Luntiala, P. Paloheimo, P. Nevala, P. Holopainen, K. Kuoppasalmi (Helsinki, Finland)
  • Gamma-hydroxybutyrate (GHB) endogenous concentrations, abuse, traffic accidents and death
    A. Eklund, M. Eriksson (Linkoping, Sweden)
  • Analysis of 100 road traffic accident fatalities in the Greater London area
    N. McLachlan-Troup, S. Brahma, S. Paterson (London, UK)
  • GC/MS screening of amphetamine-type designer drugs
    W. Romhild, U. Schmidt, R. Schoning, D. Krause, T. Daldrup (Magdeburg and Dusseldorf, Germany)
  • Mortality among drunken and drugged drivers in Norway
    S. Skurtveit, A.S. Christophersen, J. Morland (Oslo, Norway)
  • Long term stability of alcohol in blood
    J. Vasiliades, K. Ford (Omaha, NE, USA)
  • Analytical results in cases of driving under the influence in the Netherlands in view of the German and Belgian legislation
    B.E. Smink, B. Ruiter, K.J. Lusthof, P.G.M. Zweipfenning (Rijswijk, The Netherlands)
  • The use of narcotics and medicines by drunken drivers caught in traffic
    S. Rajalin, P. Lillsunde, A. Penttila, M. Portman, P. Luntiala, P. Nevala, M. Maki (Helsinki, Finland)
  • Previous crimes of drivers convicted for driving while intoxicated (DWI)
    P. Lillsunde, H. Seppa, P. Luntiala, A. Penttila (Helsinki, Finland)
  • Fatal acute alcohol intoxication in heterozygote of ALDH2
    H. Yamamoto, A. Tanegashima, H. Hosoe, T. Fukunaga (Mie, Japan)
  • Amphetamines and opiates in saliva from drugged drivers - comparison with blood concentrations
    A.S. Christophersen, A. Ripel (Oslo, Norway)
  • Screening for drugs of abuse in blood specimens using a Hitachi 917
    B. Skuterud, K.M. Olsen, B.R. Larssen, A. Smith-Kielland (Oslo, Norway)
  • In vitro degradation of cocaine in fresh unpreserved and preserved plasma with regard to benzoylecgonine, ecgonine methyl ester and ecgonine formation
    A. Klingmann, G. Skopp, L. Potsch, R. Aderjan (Heidelberg and Mainz, Germany)
  • Utility aspects of roadside tests in case of administrative offences in Germany
    S. Steinmeyer, H. Ohr, H.-J. Maurer, M.R. Moeller (Homburg and Bexbach, Germany)
  • Drugs detected among Slovenian apprehended drivers
    M. Zorec Karlovsek, G. Kozelj, A. Kustrin Samba (Ljubljana, Slovenia)

 
15:00-16:00  Poster Session III: Workplace Drug Testing
 
  • GC/MS comprehensive benzodiazepine screen statistical distribution of different drugs in routine testing in the United States
    V.P. Uralets, P.A. Gillette, F.C. Medina (San Diego, CA, USA)
  • Urine specimen validity testing for drug of abuse
    A. Mates, R. Lang, B. Gross (Tel Aviv, Israel)
  • Doping control - drug testing in the working place?
    L.L. Reys (Lisbon, Portugal)
  • Experiences of labquality external quality assessment on abused drugs in urine
    A.-R. Vanhanen, P. Lillsunde (Helsinki, Finland)
  • High performance liquid chromatographic method for determining hypoxanthine, caffeine and its metabolites in biological fluids
    E. Dali, P. Lillsunde, T. Seppala (Espoo and Helsinki, Finland)
  • A new laboratory information management system for doping control and drugs-of-abuse testing
    A. Leinonen, O. Soderlund, E. Grip, U.-M. Laakkonen, M. Viuhko, A. Saari (Helsinki, Finland)
  • Drug abuse among workers in different regions of Brazil
    O.A. Silva, M. Yonamine (Sao Paulo, Brazil)
  • Evaluation of a new online immunoassay for sensitive detection of amphetamine derivatives in urine
    A. Scholer, A. Mueller, S. Pellegrino, L. Gallo, E. Basili, H. Zhao, I. Domke (Basel, Switzerland, Torino and Chieri, Italy, Indianapolis, IN, USA and Mannheim, Germany)
  • Fast confirmation of THC-COOH by LC/MS/MS
    M. Gorner, S. Vogt, R. Goerke, W. Weinmann (Freiburg, Germany)


Wednesday 16 August
 
10:30-11:30  Poster Session IV: Postmortem Forensic Toxicology
 
  • Importance of fat tissue in OPI poisoning
    S.A. Akgur, P. Ozturk, A. Yemipcigil, B. Ege (Yzmir, Turkey)
  • Study on carbamazepine metabolism in poisonings by means of liquid chromatography with mass detection
    M. Klys, B. Bujak-Gizycka, B. Bystrowska, B. Szkolnicka (Krakow, Poland)
  • Drug related fatalities in Southern Spain (1992-1999)
    T. Soriano, C. Jurado, M. Menéndez, M. Repetto (Sevilla, Spain)
  • Lethal intoxications observed in the period 1997-1999: a statistical evaluation
    N. Fucci, N. de Giovanni, M. Chiarotti (Roma, Italy)
  • Computer-assisted identification of the general unknown in forensic samples
    Th. Stimpfl, B. Schopper, W. Vycudilik (Vienna, Austria)
  • Screening of post-mortem blood in cases of pesticide poisoning using Headspace Solid Phase Microextraction
    K. Asri, R.A. Malik, R.A. Anderson (Petaling Jaya, Malaysia and Glasgow, UK)
  • Hydrogen cyanide and carbon monoxide in blood of 35 convicted dead in a mattress fire
    L.A. Ferrari, M.G. Arado, L. Giannuzzi, M.A. Guatelli (La Plata, Argentina)
  • Fatal intoxication with aluminium phosphide - ammonium carbamate: Is atropine an appropriate antidote?
    E. Logemann, S. Vogt, B. Krutzfeldt (Freiburg, Germany)
  • A camouflaged drowning case of homicide by means of methamphetamine poisoning
    M. Kashiwagi, S. Kashimura, K. Hara, M. Kageura, A. Miyoshi, M. Takamoto, T. Hamanaka (Fukuoka, Japan)
  • Fatal overdose of the herbicide bentazone
    I.B. Muller, H. Willads Petersen (Copenhagen, Denmark)
  • Alcohols and cocaine postmortem stability in human organs and blood
    V. Garrote, D. Mirson, I. Krbavcic, C. Nardo, M. Arado, R. Nieto, C. Colangelo, L. Ferrari, Z. Wamba (La Plata, Argentina)
  • Distribution of tetracaine and its metabolite in rabbit tissue samples following spinal anesthesia
    Y. Hino, N. Ikeda, K. Kudo, A. Tsuji (Fukuoka, Japan)
  • Increase in heroin-related deaths in Metropolitan Detroit
    D.S. Isenschmid, B.R. Hepler, S. Kanluen, C.P. LoDico (Detroit, MI and Rockville, MD, USA)
  • Abuse and misuse of ethylene glycol
    H. Samkova, J. Pivnicka, A. Brzobohata, M. Hirt (Brno, Czech Republic)
  • Brain amino acid abnormalities in liver disease - a postmortem study
    F. Musshoff, P. Schmidt, B. Madea, S. Schoenemeier, T. Daldrup (Bonn and Dusseldorf, Germany)
  • Acute cardiovascular cannabis toxicity
    L. Bachs, H. Morland (Oslo, Norway)
  • The relationship between apparent volume of distribution and postmortem drug redistribution of drugs in a rat model
    T. Hilberg, A. Ripel, J. Morland (Oslo, Norway)
  • Postmortem detection and identification of sildenafil (Viagra®) and its metabolites by LC/MS and LC/MS/MS
    W. Weinmann, M. Bohnert, S. Pollak (Freiburg, Germany)
  • Serotonin, 5-hydroxyindolacetic acid and total cholesterol in blood, cerebrospinal fluid and defined brain areas in suicide and control cases
    G. Skopp, G. Zimmer, H. Walendzik, R. Mattern (Heidelberg, Germany)
  • Fatal propafenone poisoning. A case report.
    E. Novakova, E. Bradkova (Prague, Czech Republic)
  • Analysis of etorphine in post mortem specimens by HPLC-DAD
    S.P. Elliott, K.A. Hale (Birmingham, UK)
  • Drugs of abuse and fatal accidents in Latvia
    J. Volgram, T. Khodasevitch (Riga, Republic of Latvia)


Thursday 17 August
 
10:00-11:00  Poster Session V: Clinical Toxicology
 
  • Combinations of neurotransmitter medications used in homicide poisonings for with the aim of the acquaintance rape
    V. Afanasiev, R. Babaxanyan, E. Bushyev, Vl. Afanasiev (St. Petersburg, Russia)
  • The software identification of autonomous nervous system syndrome in the hospital setting and medicolegal bureau for estimating the origin of poison in the survivals after poisonings with drugs
    V. Afanasiev, R. Babaxanyan, E. Bushyev, G. Zaslavsky, E. Tzibulkin, Al. Afanasiev (St. Petersburg, Russia)
  • Determination of selective serotonin reuptake inhibitors in human serum by gas chromatography-mass spectrometry
    G. Tournel, L. Humbert, E. Vinner, V. Hedouin, M. Lhermitte, D. Gosset (Lille, France)
  • Toluene abuse in teenagers
    S.A. Akgur, P. Ozturk, S. Erturk (Yzmir, Turkey)
  • Determination of plasma methadone concentration by immunoassay
    A. Mates, R. Lang, B. Gross (Tel Aviv, Israel)
  • Acute hepatitis due to chronic consumption of herbal tea for "therapeutic" purposes
    S. Athanaselis, Ch. Fourlas, Sp. Dourakis, A. Koutselinis (Athens, Greece)
  • Sensitive determination of four general anaesthetics in whole blood by capillary gas chromatography with cryogenic oven trapping
    T. Kojima, A. Ishii, K. Watanabe-Suzuki, H. Seno, T. Kumazawa, O. Suzuki, Y. Katsumata (Nagoya, Hamamatsu and Tokyo, Japan)
  • Experimental study of hemoperfusion for removing alcohol contained in the agricultural chemicals from the circulating blood
    K. Gonmori, N. Yoshioka (Akita, Japan)
  • External quality assessment of laboratory performance in analysis of toxicology cases
    J.F. Wilson, P.A. Toseland, N.E. Capps, L.N. Sandle, B.L. Smith, G. Sweeney, A.H. Thomson, I.D. Watson, J. Williams (Cardiff, UK)
  • The neurochemical effects of cis-4-methylaminorex ("Euphoria"): a microdialysis study in the rat
    S. Ellermaa, A. Kankaanpaa, E. Meririnne, T. Seppala (Helsinki, Finland)
  • Detection of 4-methylaminorex by on-site urine immunoassays
    E. Meririnne, A. Kankaanpaa, S. Ellermaa, T. Seppala (Helsinki, Finland)
  • Relationship between concentration of morphine and codeine in serum and saliva of acutely poisoned addicts
    E. Janowska, W. Piekoszewski, J. Pach, L. Winnik (Krakow, Poland)
  • Toxicological and analytical aspects of methadone maintenance treatment of home-made heroine addicts
    W. Piekoszewski, J. Pach (Krakow, Poland)
  • Improved immunoassays versus LC-MS for benzodiazepines traces detection in urine
    B. Seigle-Ferrand, J.P. Goulle, F. Chast, J.P. Dupeyron (Paris and Le Havre, France)
  • Clinical and experimental data regarding the consequences of administration of nicardipine during pregnancy
    R. Gligor, D. Ardelean, V. Gligor (Timisoara, Romania)
  • Metabolic phenotyping and genotype of dextromethorphan
    H.S. Chung, W.K. Yang, H.K. Choi, W.T. Jin, Y.K. Yang, H.K. Roh, Y.C. Yoo (Seoul and Inchon, Korea)
  • Analysis of 4-methylthioamphetamine (4-MTA) in clinical specimens
    S.P. Elliott (Birmingham, UK)
  • Attempted suicide by self poisoning: a growing problem in Egypt
    L.A.M. Abd El-Megid (Alexandria, Egypt)

 
10:00-11:00  Poster Session VI: Forensic and Environmental Toxicology
 
  • Environmental exposure to mercury in Alexandria, Egypt
    E.M. Salem, E. Shalaby, M.M. Zahran (Alexandria, Egypt)
  • Dietary plants - an unrecognised exposure route for microcystins?
    J. Meriluoto, M. Solin, L. Spoof, K. Lahti, T. Lindholm (Turku, Helsinki and Emkarby, Finland)
  • Detection of rotenticide difenacoum in liver, stomach, and small intestine of a poisoned dog by HPLC-DAD
    A. Pelander (Helsinki, Finland)
  • Identification of psilocin in urine
    A. Eklund, S. Steffenrud (Linkoping, Sweden)
  • Determination of organophosphorus pesticides in issues by solid phase micro-extraction and gas chromatography
    S. Zang, Z. Huang, Y. Lin, H. Wu (Fuzhou, P.R. China)
  • Effect of environmental pollution on human health
    S.K. Gupta, D.N. Bhardwaj, R.K. Sharma, T.D. Dogra, M. Kumari (New Delhi, India)
  • Toxicity of aflatoxin B1 in recombinant saccharomyches cerevisiae yeast cells
    R.O. Juvonen (Kuopio, Finland)
  • Determination of sodium fluoroacetate (1080) derivatives in biological tissues by GC/NPD
    F. Shizhen, W. Zhaohong, Y. Zhongshan, H. Yi (Beijing, P.R. China)
  • Interrelationship between the concentration of toxic and essential elements in Korean tissues
    Y.C. Yoo, S.K. Lee, J.Y.Yang, S.W. In, K.W. Kim, H.S. Lee, Y.C. Ko, K.H. Chung (Seoul and Suwon, Korea)
  • Determination of arsenic species from soil samples
    Y. Higashikawa, O. Ohtsuru, Y. Marumo (Kashiwa, Japan)
  • Stability of lacriminators in water and wipe samples
    M. Kataoka, K. Tsuge, Y. Seto, M. Noami (Chiba and Wakayama, Japan)
  • Mutagenic effects of the food colour fast green in rats
    M. Ali, H.A. Mekkawy, A.A. El-Ghor, A.A. Sharaf, M.M. Montaser (Cairo and Giza, Egypt)
  • Toxic effects of herbicides on the liver and kidney of rats
    H.A. Mekkawy, H.M. Shouman (Cairo, Egypt)
  • United Nations and its role in training for the identification and analysis of drugs
    I. Naidis, P. Lillsunde, R. Anderson, H. Stead (Vienna, Austria, Helsinki, Finland and Glasgow, UK)
  • Effect of storage temperature on endogenous GHB levels in urine
    M.A. LeBeau, M.L. Miller, B. Levine (Washington, DC and Baltimore, MD, USA)
  • Toxicokinetics of carisoprodol in rat
    H.K. Choi, W.K. Yang, S.C. Kim, E.Y. Han, H.S. Chung, Y.C. Yoo, M.Y. Pyo (Seoul, Korea)
  • Blood matrix effects: How reliable is a calibration with standards in pure methanol?
    M. Schmid, S. Waldvogel, P.X. Iten (Zurich, Switzerland)
  • Detection of methylenedioxyphenylalkylamine designer drugs in urine by using a New High Sensitive OnLine Amphetamine Assay
    H. Zhao, K. Goc-Szkutnicka, J. Zhao, M. Zion, A.J. McNally, S.J. Salamone (Indianapolis, IN, USA)
  • UNDCP international quality assurance programme: current status
    A.H. Stead, R.M. Aguado-Bombin, R.A. Anderson, R.K. Bramley, D.G. Clarke, R. de la Torre (Vienna, Austria, Glasgow and Birmingham, UK, Hong Kong SAR, China and Barcelona, Spain)

 
14:00-15:00  Poster Session VII: Alternative Matrices
 
  • Comparison of self-report, urine analysis and hair analysis in 170 patients attending a methadone treatment centre
    S. Paterson, R. Cordero, S. Carmen, M. McPhilips (London, UK)
  • Detection times of cocaine and metabolites in plasma, saliva and urine following repeated oral administration
    R.A. Jufer, S.L. Walsh, A. Tsadik, E.J. Cone (Baltimore, MD, USA)
  • Analysis of amphetamines and other basic drugs in hair by combined alkaline digestion, headspace solid-phase microextraction and derivatization
    F. Sporkert, F. Pragst (Berlin, Germany)
  • Opiates and methadone hair analysis in detoxification and methadone treatment programme
    R. Stanaszek, W. Piekoszewski, R. Wietecha, B. Karakiewicz, T. Kozielec (Krakow and Szczecin, Poland)
  • Quantitation of cocaine, benzoylecgonine and cocaethylene in saliva with LC/MS/MS using small sample volumes
    K. Clauwaert, J. Van Bocxlaer, T. Decaestecker, K. Mortier, W. Lambert, E. Van den Eeckhout, C. Van Peteghem, A. De Leenheer (Gent, Belgium)
  • Acetylcodeine in hair as a marker of illicit heroin consumption
    C. Girod, O. Plaut, C. Staub (Genève, Switzerland)
  • Determination of clozapine in dipterous maggots on decomposing carcasses
    J.M.C. van Wyk, T.C. van der Linde, H.K.L. Hundt (Bloemfontein, South Africa)
  • Hair analysis for benzodiazepines with ion spray LC-MS
    R. Kronstrand, M. Josefsson, I. Nystrom (Linkoping, Sweden)
  • A comparison between on-site immunoassay drug-testing devices and laboratory results
    M. Gronholm, P. Lillsunde (Helsinki, Finland)
  • In vitro experiments on melanin association and drug desorption of 3H-cocaine/BZE and 3H-haloperidol
    L. Potsch, P. Emmerich, G. Skopp (Mainz and Heidelberg, Germany)
  • Quality of cocaine in the street-drug market of Sao Paulo city, Brazil
    D.G. Carvalho, A.F. Midio (Saùo Paulo, Brazil)
  • Collection and comparative analysis of blood, urine and saliva specimens from a Scottish prison
    C.M. Morrison, R.A. Anderson, J.S. Oliver, N. Royle (Glasgow and Edinburgh, UK)


 

General information please contact
Dr Ilkka Ojanperä
Department of Forensic Medicine, PO BOX 40, FIN 00014
University of Helsinki, Helsinki, Finland.
fax + 358-9-1912 7518; tel. +358-9-1912 7487; e-mail: ilkka.ojanpera@helsinki.fi